¥25,400+85.00 (+0.34%)
HOYA Corporation, a med-tech company, provides high-tech and medical products in the Japan, Asia, the Americas, Europe, and internationally.
HOYA Corporation in the Healthcare sector is trading at ¥25,400 with a market capitalization of $8.7T. Wall Street consensus targets ¥30,200 (15 analysts), implying a +18.9% move over the next 12 months. The stock is currently 16% below its 52-week high of ¥30,400, remaining 2.5% below its 200-day moving average. Risk note: RSI 81 is overbought against a weak tape. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
| Metric (JPY) · Annual | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
| Total Revenue | ¥734.10B↓ | ¥792.63B↓ | ¥885.82B↓ | ¥995.84B |
| Gross Profit | ¥631.86B↓ | ¥687.99B↓ | ¥766.25B↓ | ¥859.94B |
| Operating Income | ¥400.86B↓ | ¥433.45B↓ | ¥480.79B↓ | ¥551.13B |
| Net Income | ¥168.64B↓ | ¥181.38B↓ | ¥202.10B↓ | ¥253.08B |
HOYA Corporation, a med-tech company, provides high-tech and medical products in the Japan, Asia, the Americas, Europe, and internationally. The company operates through two segments: Life Care, and Information and Communications. It offers life care...